BioCentury
ARTICLE | Company News

Compugen deal

January 10, 2011 8:00 AM UTC

Compugen received $5 million in R&D funding from investment firm Baize Investments Ltd. to support Compugen's Pipeline Program, which consists of more than 30 mAbs and proteins in discovery and precli...